known procedure.7 Oxidative cleavage of the diol 2 followed
by Horner-Wadsworth-Emmons reaction afforded the R,â-
unsaturated ester 3 in 70% overall yield (Scheme 1).
mixtures 99a and 109b in 86% yield, the ratio of which was
>26:1 (Scheme 2). The structure of the major product 9 was
Scheme 2
Scheme 1
confirmed by its spectral data. The stereoselective formation
of 9 could be explained by assuming the cyclization proceed
via transition state A. Transition state B, which leads to 10,
would be disadvantageous because of nonbonding gauche
repulsion between the Boc group and the π-allyl-oxy
palladium complex.
Conversion of 9 to 1-deoxymannojirimycin (1) was
effected by the three-step sequence shown in Scheme 3.
Scheme 3
Reduction of the ester group of 3 and protection of the
resulting alcohol by the pivaloyl (Piv) group gave, in 88%
yield, the pivaloyl ester, which was treated with hydrochloric
acid to give the diol 4 in 95% yield. Tosylation of the diol
4 followed by treatment with potassium carbonate gave the
epoxide 5 in 76% yield.
Regioselective ring-opening of 5 with sodium azide and
subsequent protection of the resulting alcohol with the
methoxy methyl group gave the azide 6 in 39% yield.
Reduction by PPh3 and protection of the resulting amine
gave, in 44% yield, the pivaloyl ester 7, the pivaloyl group
of which was deprotected to afford the allyl alcohol 8 in a
quantitative yield.8
The allyl alcohol 8 was treated with 15 mol % PdCl2(CH3-
CN)2 in THF at room temperature to give the cyclized
Ozonolysis of 9 and reductive workup (NaBH4) gave the
alcohol 11 in 92% yield. Removal of the benzyl group and
the N-tert-butoxy carbonyl group (Boc) in 11 [TFA, CH2-
Cl2; H2, Pd/C, EtOH] afforded 1-deoxymannojirimycin (1),
(6) (a) Meyers, A. I.; Andres, C. J.; Resek, J. E.; Woodall, C. C.;
McLaughlin, M. A.; Lee, P. H.; Price, D. A. Tetrahedron 1999, 55, 8931.
(b) Cook, G. R.; Beholz, L. G.; Stille, J. R. J. Org. Chem. 1994, 59, 3575.
(7) This procedure was three steps (overall 25% yield). cf. Takano, S.;
Ogasawara, K. J. Synth. Org. Chem., Jpn. 1987, 45, 1157 and references
therein.
1
(9) (a) Data of 9: [R]26 -1.21° (c 1.16, CHCl3); H NMR (400 MHz,
D
CDCl3) δ ) 7.39-7.22 (m, 10H), 6.00 (ddd, J ) 6.2, 10.0, 17.6 Hz, 1H),
5.08 (dd, J ) 2.5, 11, 7 Hz, 1H), 5.00-4.75 (br, 1H), 4.73-4.62 (m, 4H),
4.58 (d, J ) 12.2 Hz, 1H), 4.43 (d, J ) 12.0 Hz, 1H), 4.06 (brd, 1H), 3.94
(ddd, J ) 3.0, 4.9, 11.2, Hz, 1H), 3.82 (t, J ) 3.1 Hz, 1H), 3.72-3.61 (m,
1H), 3.35 and 3.34 (two s, 3H), 3.23 (t, J ) 12.0 Hz, 1H), 1.45 (s, 9H); IR
(neat) 1694(CdO) cm-1. Anal. Calcd for C28H37NO6: C, 69.54; H, 7.71;
N, 2.90. Found: C, 69.54; H, 7.70; N, 2.66. (b) Data of 10: 1H NMR (400
MHz, CDCl3) δ ) 7.41-7.21 (m, 10H), 6.08 (ddd, J ) 3.7, 10.7, 17.6 Hz,
1H), 5.27 (brd, 1H), 5.13 (brd, 1H), 4.86-4.66 (m, 7H), 4.20-4.03 (m,
2H), 3.99-3.92 (m, 1H), 3.45 (dd, J ) 3.2, 10.2 Hz, 1H), 3.41 (s, 3H),
2.96-2.73 (m, 1H), 1.45 (s, 9H).
(8) Data of 8: [R]28D 35.1° (c 1.15, CHCl3); 1H NMR (400 MHz, CDCl3)
δ 7.36-7.24 (m, 10H), 5.99 (ddd, J ) 4.6, 5.9, 15.6 Hz, 1H), 5.66 (dd, J
) 8.1, 15.6 Hz, 1H), 5.14-5.06 (m, 1H), 4.76 (d, J ) 12.0 Hz, 1H), 4.73
(d, J ) 12.0 Hz, 1H), 4.61 (d, J ) 6.8 Hz, 1H), 4.59 (d, J ) 11.7 Hz, 1H),
4.54 (d, J ) 6.8 Hz, 1H), 4.38 (d, J ) 11.7 Hz, 1H), 4.20 (dd, J ) 4.6,
13.4 Hz, 1H), 4.14 (dd, J ) 5.9, 13.4 Hz, 1H), 3.97 (brt, 1H), 3.81-3.74
(m, 2H), 3.53 (ddd, J ) 2.4, 8.1, 14.4 Hz, 1H), 3.36 (s, 3H), 3.13 (ddd, J
) 4.4, 8.1, 14.4 Hz, 1H), 1.41 (s, 9H); IR (neat) 3434 (NH, OH), 1695
(CdO) cm-1. Anal. Calcd for C28H39NO7: C, 67.04; H, 7.84; N, 2.79; O,
22.33. Found: C, 67.22; H, 8.08; N, 2.54; O, 22.16
2428
Org. Lett., Vol. 2, No. 16, 2000